1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GLOBAL MACULAR DEGENERATION TESTING AND THERAPEUTICS MARKET BY TYPE
5.1. Introduction
5.2. Dry
5.2.1. Market Opportunities and Trends
5.2.2. Growth Prospects
5.2.3. Geographic Lucrativeness
5.3. Wet
5.3.1. Market Opportunities and Trends
5.3.2. Growth Prospects
5.3.3. Geographic Lucrativeness
6. GLOBAL MACULAR DEGENERATION TESTING AND THERAPEUTICS MARKET BY GEOGRAPHY
6.1. Introduction
6.2. North America
6.2.1. By Type
6.2.2. By Country
6.2.2.1. USA
6.2.2.1.1. Market Opportunities and Trends
6.2.2.1.2. Growth Prospects
6.2.2.2. Canada
6.2.2.2.1. Market Opportunities and Trends
6.2.2.2.2. Growth Prospects
6.2.2.3. Mexico
6.2.2.3.1. Market Opportunities and Trends
6.2.2.3.2. Growth Prospects
6.3. South America
6.3.1. By Type
6.3.2. By Country
6.3.2.1. Brazil
6.3.2.1.1. Market Opportunities and Trends
6.3.2.1.2. Growth Prospects
6.3.2.2. Argentina
6.3.2.2.1. Market Opportunities and Trends
6.3.2.2.2. Growth Prospects
6.3.2.3. Others
6.3.2.3.1. Market Opportunities and Trends
6.3.2.3.2. Growth Prospects
6.4. Europe
6.4.1. By Type
6.4.2. By Country
6.4.2.1. United Kingdom
6.4.2.1.1. Market Opportunities and Trends
6.4.2.1.2. Growth Prospects
6.4.2.2. Germany
6.4.2.2.1. Market Opportunities and Trends
6.4.2.2.2. Growth Prospects
6.4.2.3. France
6.4.2.3.1. Market Opportunities and Trends
6.4.2.3.2. Growth Prospects
6.4.2.4. Italy
6.4.2.4.1. Market Opportunities and Trends
6.4.2.4.2. Growth Prospects
6.4.2.5. Others
6.4.2.5.1. Market Opportunities and Trends
6.4.2.5.2. Growth Prospects
6.5. Middle East and Africa
6.5.1. By Type
6.5.2. By Country
6.5.2.1. Saudi Arabia
6.5.2.1.1. Market Opportunities and Trends
6.5.2.1.2. Growth Prospects
6.5.2.2. Israel
6.5.2.2.1. Market Opportunities and Trends
6.5.2.2.2. Growth Prospects
6.5.2.3. Others
6.5.2.3.1. Market Opportunities and Trends
6.5.2.3.2. Growth Prospects
6.6. Asia Pacific
6.6.1. By Type
6.6.2. By Country
6.6.2.1. China
6.6.2.1.1. Market Opportunities and Trends
6.6.2.1.2. Growth Prospects
6.6.2.2. Japan
6.6.2.2.1. Market Opportunities and Trends
6.6.2.2.2. Growth Prospects
6.6.2.3. India
6.6.2.3.1. Market Opportunities and Trends
6.6.2.3.2. Growth Prospects
6.6.2.4. South Korea
6.6.2.4.1. Market Opportunities and Trends
6.6.2.4.2. Growth Prospects
6.6.2.5. Indonesia
6.6.2.5.1. Market Opportunities and Trends
6.6.2.5.2. Growth Prospects
6.6.2.6. Thailand
6.6.2.6.1. Market Opportunities and Trends
6.6.2.6.2. Growth Prospects
6.6.2.7. Taiwan
6.6.2.7.1. Market Opportunities and Trends
6.6.2.7.2. Growth Prospects
6.6.2.8. Others
6.6.2.8.1. Market Opportunities and Trends
6.6.2.8.2. Growth Prospects
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Market Share Analysis
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Competitive Dashboard
8. COMPANY PROFILES
8.1. Good-Lite Company
8.2. Leica Microsystems
8.3. Optovue, Inc
8.4. Heidelberg Engineering GmbH
8.5. Topcon
8.6. Nano Retina
8.7. Macuhealth
8.8. LumiThera, Inc
8.9. Ellex Medical Lasers
8.10. Quantel Medical